Lei Liu1, Qiansheng Wu2, Hong Yan1, Baoxian Chen1, Xilong Zheng3, Qiang Zhou1. 1. Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. 2. Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. 3. Department of Biochemistry and Molecular Biology, Cumming School of Medicine, Libin Cardiovascular Institute of Alberta, University of Calgary, Alberta, Canada.
Abstract
OBJECTIVE: Cardiac autonomic neuropathy (CAN) is a common and serious complication of diabetes mellitus with various systemic involvements, such as atherosclerotic cardiovascular disease. We aimed to evaluate the association between CAN and coronary artery lesions in patients with type 2 diabetes. Research Design and Methods. We retrospectively reviewed the medical records of 104 patients with type 2 diabetes and coronary artery disease (CAD). We evaluated heart rate variability (HRV) parameters (SDANN, SDNN, and pNN50) to assess cardiac autonomic function. The severity of coronary lesions was assessed by the Gensini scores and the number of affected vessels. Correlation analyses between HRV parameters and the severity of coronary lesions and clinical parameters were performed. RESULTS: Spearman's correlation analysis showed a significant negative correlation between SDANN and Gensini scores (r = -0.22, P = 0.03). Interestingly, this finding remained significant after adjusting for clinical covariates (r = -0.23, P = 0.03). However, there was no association between HRV parameters and the severity of coronary lesions as assessed by the number of affected vessels. Clinical parameters were not significantly correlated with HRV parameters (all P > 0.05). CONCLUSIONS: Cardiac autonomic neuropathy might be related to the degree of coronary atheromatous burden in patients with type 2 diabetes. Screening for cardiac autonomic neuropathy might potentially be beneficial in the risk stratification of patients with type 2 diabetes.
OBJECTIVE: Cardiac autonomic neuropathy (CAN) is a common and serious complication of diabetes mellitus with various systemic involvements, such as atherosclerotic cardiovascular disease. We aimed to evaluate the association between CAN and coronary artery lesions in patients with type 2 diabetes. Research Design and Methods. We retrospectively reviewed the medical records of 104 patients with type 2 diabetes and coronary artery disease (CAD). We evaluated heart rate variability (HRV) parameters (SDANN, SDNN, and pNN50) to assess cardiac autonomic function. The severity of coronary lesions was assessed by the Gensini scores and the number of affected vessels. Correlation analyses between HRV parameters and the severity of coronary lesions and clinical parameters were performed. RESULTS: Spearman's correlation analysis showed a significant negative correlation between SDANN and Gensini scores (r = -0.22, P = 0.03). Interestingly, this finding remained significant after adjusting for clinical covariates (r = -0.23, P = 0.03). However, there was no association between HRV parameters and the severity of coronary lesions as assessed by the number of affected vessels. Clinical parameters were not significantly correlated with HRV parameters (all P > 0.05). CONCLUSIONS: Cardiac autonomic neuropathy might be related to the degree of coronary atheromatous burden in patients with type 2 diabetes. Screening for cardiac autonomic neuropathy might potentially be beneficial in the risk stratification of patients with type 2 diabetes.
Authors: Julian W Sacre; Bennett Franjic; Christine L Jellis; Carly Jenkins; Jeff S Coombes; Thomas H Marwick Journal: JACC Cardiovasc Imaging Date: 2010-12
Authors: K Malmberg; S Yusuf; H C Gerstein; J Brown; F Zhao; D Hunt; L Piegas; J Calvin; M Keltai; A Budaj Journal: Circulation Date: 2000-08-29 Impact factor: 29.690
Authors: Jonathan D Newman; Arthur Z Schwartzbard; Howard S Weintraub; Ira J Goldberg; Jeffrey S Berger Journal: J Am Coll Cardiol Date: 2017-08-15 Impact factor: 24.094
Authors: Julian P J Halcox; William H Schenke; Gloria Zalos; Rita Mincemoyer; Abhiram Prasad; Myron A Waclawiw; Khaled R A Nour; Arshed A Quyyumi Journal: Circulation Date: 2002-08-06 Impact factor: 29.690
Authors: Stephen A Johnson; Kamal Shouman; Shahar Shelly; Paola Sandroni; Sarah E Berini; P James B Dyck; Ernest Matthew Hoffman; Jay Mandrekar; Zhiyv Niu; Christopher J Lamb; Phillip A Low; Wolfgang Singer; Michelle L Mauermann; John Mills; Divyanshu Dubey; Nathan P Staff; Christopher J Klein Journal: Neurology Date: 2021-10-27 Impact factor: 9.910